Hartjes Katherine A, Li Xing, Martinez-Fernandez Almudena, Roemmich Alexa J, Larsen Brandon T, Terzic Andre, Nelson Timothy J
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Stem Cells. 2014 Sep;32(9):2350-9. doi: 10.1002/stem.1734.
The value of induced pluripotent stem cells (iPSCs) within regenerative medicine is contingent on predictable and consistent iPSC differentiation. However, residual influence of the somatic origin or reprogramming technique may variegate differentiation propensity and confound comparative genotype/phenotype analyses. The objective of this study was to define quality control measures to select iPSC clones that minimize the influence of somatic origin on differentiation propensity independent of the reprogramming strategy. More than 60 murine iPSC lines were derived from different fibroblast origins (embryonic, cardiac, and tail tip) via lentiviral integration and doxycycline-induced transgene expression. Despite apparent equivalency according to established iPSC histologic and cytomorphologic criteria, clustering of clonal variability in pluripotency-related gene expression identified transcriptional outliers that highlighted cell lines with unpredictable cardiogenic propensity. Following selection according to a standardized gene expression profile calibrated by embryonic stem cells, the influence of somatic origin on iPSC methylation and transcriptional patterns was negated. Furthermore, doxycycline-induced iPSCs consistently demonstrated earlier differentiation than lentiviral-reprogrammed lines using contractile cardiac tissue as a measure of functional differentiation. Moreover, delayed cardiac differentiation was predominately associated with upregulation in pluripotency-related gene expression upon differentiation. Starting from a standardized pool of iPSCs, relative expression levels of two pluripotency genes, Oct4 and Zfp42, statistically correlated with enhanced cardiogenicity independent of somatic origin or reprogramming strategy (R(2) = 0.85). These studies demonstrate that predictable iPSC differentiation is independent of somatic origin with standardized gene expression selection criteria, while the residual impact of reprogramming strategy greatly influences predictable output of tissue-specification required for comparative genotype/phenotype analyses.
诱导多能干细胞(iPSC)在再生医学中的价值取决于可预测且一致的iPSC分化。然而,体细胞来源或重编程技术的残留影响可能会使分化倾向多样化,并混淆比较基因型/表型分析。本研究的目的是确定质量控制措施,以选择能将体细胞来源对分化倾向的影响降至最低的iPSC克隆,且不受重编程策略的影响。通过慢病毒整合和强力霉素诱导的转基因表达,从不同的成纤维细胞来源(胚胎、心脏和尾尖)获得了60多个小鼠iPSC系。尽管根据既定的iPSC组织学和细胞形态学标准看似等效,但多能性相关基因表达中的克隆变异性聚类识别出了转录异常值,突出了具有不可预测的心肌发生倾向的细胞系。根据由胚胎干细胞校准的标准化基因表达谱进行选择后,体细胞来源对iPSC甲基化和转录模式的影响被消除。此外,以收缩性心脏组织作为功能分化的指标,强力霉素诱导的iPSC始终比慢病毒重编程的细胞系表现出更早的分化。此外,延迟的心脏分化主要与分化时多能性相关基因表达的上调有关。从标准化的iPSC库开始,两个多能性基因Oct4和Zfp42的相对表达水平与增强的心肌发生能力在统计学上相关,且不受体细胞来源或重编程策略的影响(R(2) = 0.85)。这些研究表明,通过标准化的基因表达选择标准,可预测的iPSC分化与体细胞来源无关,而重编程策略的残留影响极大地影响了比较基因型/表型分析所需的组织特异性的可预测输出。